✦ LIBER ✦

Gene therapy for dyslipidemia: Clinical prospects

✍ Scribed by Daniel J. Rader; Uwe J. F. Tietge

Book ID: 107534424
Publisher: Current Science Inc.
Year: 1999
Tongue: English
Weight: 713 KB
Volume: 1
Category: Article
ISSN: 1523-3804
DOI: 10.1007/s11883-999-0051-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospects for intravascular gene therapy

✍ Roy C. Smith; Kenneth Walsh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

The goal of this review is to provide an overview of gene delivery systems and candidate genes currently being evaluated for genetic strategies in vascular gene therapy. We will discuss treatment strategies that have been shown by in vivo model systems to be efficacious in promoting neovascularizati

Liver-directed gene therapy for dyslipid

Liver-directed gene therapy for dyslipidemia and diabetes

✍ Kazuhiro Oka; Lawrence Chan 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 371 KB

Recent advances in liver-directed gene t

Recent advances in liver-directed gene therapy for dyslipidemia

✍ Kazuhiro Oka; Lawrence Chan 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 419 KB

Nutrition therapy for dyslipidemia

✍ Jo Ann S. Carson 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 389 KB

Biologic therapies for dyslipidemia

✍ Michael H. Davidson 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 239 KB

Inducible control of gene expression: pr

Inducible control of gene expression: prospects for gene therapy

✍ iane M Harvey; C Thomas Caskey 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 793 KB

A number of drug-related gene expression systems are available for controlling target gene transcription through the use of small-molecule inducing compounds. While the utility of such systems has been demonstrated in vitro and in transgenic mice, recent improvements are likely to make these systems